NCT04561102View on ClinicalTrials.gov

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

CompletedOBSERVATIONAL
Enrollment

644

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
SARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Diagnostic test for detection of SARS-CoV-2

The COVIDSeq is designed to test RNA extracted from NP swab specimens from patients symptomatic for COVID-19

Trial Locations (1)

32789

Rollins College Alfonds Sports Center, Winter Park

Sponsors

Lead Sponsor

Illumina, Inc.
All Listed Sponsors
collaborator

Helix OpCo, LLC

UNKNOWN

lead

Illumina, Inc.

INDUSTRY